BGI Genomics

RU-friendly

China's genomics powerhouse — CRISPR-based diagnostics kits, DNBSEQ sequencing for pathogen identification, and large-scale COVID diagnostics infrastructure deployed in 80+ countries.

Country: China
Revenue: CNY 3B
Employees: ~10,000 emp

ISO 13485 CE-IVD NMPA GMP

Coverage

	CN	EU	IN	US
bioinformatics-omics	✓	✓	—	✓
cross-sector-intersections	✓	✓	✓	✓
diagnostics-medtech	✓	✓	✓	✓
ecosystem-restoration	✓	✓	✓	✓
finance-investment	✓	✓	—	✓
foundries-design	✓	✓	—	✓
monitoring-conservation	✓	✓	✓	✓
regenerative-personalized	✓	✓	—	✓

Regulatorsfdaemanmpausda-aphismoa-chinaefsaepaademe

Verifiable facts

Fact	Value	Source
Funding	$80 million USD raised in IPO (2017-07-17)	fiercebiotech.com
Headquarters	Shenzhen, Guangdong Province, China (2026-08-31)	bgi.com
Revenue	3.705 billion CNY (3,705,385,018.37 CNY) for 2025 fiscal year (2025-12-31)	static.cninfo.com.cn
Production site	Addis Ababa, Ethiopia (COVID-19 testing kit production factory) (2020-09-30)	en.genomics.cn
Capacity	Ethiopia factory annual output of 10 million COVID-19 testing kits (2022-12-31)	en.genomics.cn
Certification	EU CE certification for monkeypox nucleic acid detection kit and COVID-19 antigen detection kit (colloidal gold method) (2022-12-31)	en.genomics.cn
Regulatory approval	Emergency approval from China NMPA for COVID-19 detection kits and DNBSEQ-T7 sequencing system (2020-01-26)	en.genomics.cn

Independent sources: bgi.com · en.genomics.cn · fiercebiotech.com · static.cninfo.com.cn

Technologies

Name	Cluster	Risk
Biodiversity credits	finance-investment	Low	→
Biodiversity genomics	ecosystem-restoration	Low	→
Bioinformatics & multi-omics	bioinformatics-omics	Low	→
Biological authentication & identification	cross-sector-intersections	Low	→
CRISPR diagnostics	diagnostics-medtech	Medium	→
De-extinction & conservation biotech	monitoring-conservation	Medium	→
Diagnostics & biosensors	diagnostics-medtech	Low	→
DNA synthesis & gene foundry	foundries-design	Low	→
DTC genetic testing	diagnostics-medtech	Medium	→
FemTech biotech & women's health	regenerative-personalized	Medium	→
Forest & agroecosystem biomonitoring (smart)	ecosystem-restoration	Low	→
Genomic pathogen surveillance (service)	diagnostics-medtech	Medium	→
Invasive-species biomonitoring via eDNA	monitoring-conservation	Low	→
Personalized diagnostics	diagnostics-medtech	Low	→
Personalized nutrition	regenerative-personalized	Medium	→
Single-cell omics	bioinformatics-omics	Low	→
Sovereign genome databases (plants, animals, microbes)	monitoring-conservation	Medium	→
Spatial transcriptomics & spatial multi-omics	bioinformatics-omics	Low	→

Compiled by BIOECON from primary sources.

Compliance Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.